1. Home
  2. WKHS vs ELOX Comparison

WKHS vs ELOX Comparison

Compare WKHS & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$3.09

Market Cap

40.3M

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$18.27

Market Cap

41.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WKHS
ELOX
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
40.3M
41.0M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
WKHS
ELOX
Price
$3.09
$18.27
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
75.7K
52.9K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
86.92
41.67
EPS
N/A
N/A
Revenue
$763,173.00
N/A
Revenue This Year
$89.23
N/A
Revenue Next Year
$28.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$10.00
52 Week High
$11.80
$19.96

Technical Indicators

Market Signals
Indicator
WKHS
ELOX
Relative Strength Index (RSI) 50.65 65.51
Support Level $2.76 $10.74
Resistance Level $3.50 $19.36
Average True Range (ATR) 0.24 2.09
MACD 0.01 0.44
Stochastic Oscillator 49.50 83.42

Price Performance

Historical Comparison
WKHS
ELOX

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: